Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Department of General Surgery, General Hospital of Northern Theater Command, Shenyang, China.
Gene. 2024 May 30;909:148265. doi: 10.1016/j.gene.2024.148265. Epub 2024 Feb 10.
MicroRNAs (miRNAs) have emerged as important regulators of gene expression, and the deregulation of their activity has been linked to the onset and progression of a variety of human malignancies. Among these miRNAs, miR-136-5p has attracted significant attention due to its diverse roles in cancer biology. Mostly, miR-136-5p is downregulated in malignancies. It could inhibit viability, proliferation, migration, invasion and promote apoptosis of tumor cells. This review article provides a comprehensive overview of the current understanding of miR-136-5p in different sorts of human cancers: genital tumors, head and neck tumors, tumors from the digestive and urinary systems, skin cancers, neurologic tumors, pulmonary neoplasms and other cancers by discussing its molecular mechanisms, functional roles, and impact in chemotherapies. In conclusion, miR-136-5p could be a promising new biomarker and potential clinical therapeutic target.
微小 RNA(miRNAs)已成为基因表达的重要调控因子,其活性失调与多种人类恶性肿瘤的发生和发展有关。在这些 miRNA 中,miR-136-5p 因其在癌症生物学中的多种作用而受到广泛关注。大多数情况下,miR-136-5p 在恶性肿瘤中下调。它可以抑制肿瘤细胞的活力、增殖、迁移、侵袭并促进其凋亡。通过讨论其分子机制、功能作用以及对化疗的影响,本文全面概述了 miR-136-5p 在不同类型的人类癌症(生殖系统肿瘤、头颈部肿瘤、消化系统和泌尿系统肿瘤、皮肤癌、神经肿瘤、肺部肿瘤和其他癌症)中的研究进展。总之,miR-136-5p 可能成为有前途的新型生物标志物和潜在的临床治疗靶点。